
FDA relaxes AI medical oversight: 1,000 unreviewed diagnostic apps
The FDA just made it easier for AI diagnostic tools to reach the market without review—but 95% of already-approved devices never report safety issues. Meanwhile, Epic and Cerner face unfair competition from startups bypassing regulation, and ChatGPT diagnoses differently based on patient race.










